Bionano Genomics ain’t going out-of-business.
Post# of 47
(Total Views: 56)
Posted On: 05/09/2025 7:29:54 PM
Bionano Genomics ain’t going out-of-business.
Several financially sound research institutions and organizations are actively combining Next-Generation Sequencing (NGS) with Optical Genome Mapping (OGM).
Researchers at Johns Hopkins have published studies demonstrating how OGM outperforms traditional cytogenetic assays and complements NGS in cancer research.
University of California, San Francisco researchers have combined OGM with NGS to improve detection of clinically relevant genetic variants, particularly in genetic disease research.
MD Anderson Cancer Center has explored the integration of OGM and NGS for structural variant profiling in myelodysplastic syndrome (MDS) research.
Children’s Hospital Los Angeles researchers here have used OGM and RNA sequencing to improve molecular subtyping in pediatric leukemia cases.
These institutions are well-established and financially robust.
Several financially sound research institutions and organizations are actively combining Next-Generation Sequencing (NGS) with Optical Genome Mapping (OGM).
Researchers at Johns Hopkins have published studies demonstrating how OGM outperforms traditional cytogenetic assays and complements NGS in cancer research.
University of California, San Francisco researchers have combined OGM with NGS to improve detection of clinically relevant genetic variants, particularly in genetic disease research.
MD Anderson Cancer Center has explored the integration of OGM and NGS for structural variant profiling in myelodysplastic syndrome (MDS) research.
Children’s Hospital Los Angeles researchers here have used OGM and RNA sequencing to improve molecular subtyping in pediatric leukemia cases.
These institutions are well-established and financially robust.
(0)
(0)Bionano Genomics Inc. (BNGO) Stock Research Links
Scroll down for more posts ▼